HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Benign fibroadenoma — Clinical Guidelines

Overview

Benign fibroadenomas are common solid breast tumors composed of glandular and stromal elements, typically found in young women, often presenting as palpable masses with characteristic imaging features. 1 2

Diagnosis

Clinical Presentation: Palpable breast masses, usually painless.

Imaging: Mammography and ultrasound are crucial; fibroadenomas appear well-defined, round, with smooth borders and homogeneous echogenicity on ultrasound. 1

Biopsy: Core needle biopsy or fine-needle aspiration confirms diagnosis histologically.

DNA Ploidy: Rarely used but can differentiate benign from potentially malignant lesions, though limited data in benign lesions. 3

Management

Cryotherapy: Percutaneous ultrasonographically-guided cryotherapy using a cryoprobe under local anesthesia is effective with minimal complications, suitable for reducing mass effect and improving cosmesis. 1

Surgical Excision: Recommended for giant fibroadenomas to prevent breast deformity; a circumareolar incision technique minimizes scarring. 2

Observation: Small, asymptomatic fibroadenomas may be monitored without intervention, especially in younger patients.

Special Populations

Pediatrics: Management often involves observation or minimally invasive techniques like cryotherapy due to the benign nature and potential for regression. 1

Elderly: Surgical excision may be preferred for symptomatic relief and to rule out malignancy, though less common due to lower incidence.

Comorbidities: No specific adjustments noted; treatment choice depends on tumor size and patient preference.

Key Recommendations

Consider percutaneous cryotherapy for symptomatic fibroadenomas in young women to minimize complications and improve cosmesis (Evidence: Moderate) 1

For giant fibroadenomas, employ a circumareolar incision technique to reduce scarring and maintain cosmetic outcomes (Evidence: Expert opinion) 2

Asymptomatic small fibroadenomas in pediatric patients may be safely monitored without immediate intervention (Evidence: Expert opinion) 1

References

1 Littrup PJ, Freeman-Gibb L, Andea A, White M, Amerikia KC, Bouwman D et al.. Cryotherapy for breast fibroadenomas. Radiology 2005. link 2 Naraynsingh V, Maharaj D, Rampaul R. "Swiss-roll" operation for giant fibroadenomas. The breast journal 2002. link 3 Locker AP, Dilks B, Ellis IO, Elston CW, Blamey RW. DNA ploidy in fibroadenomas (abstract). British journal of clinical practice. Supplement 1989. link 4 Naraynsingh V, Raju GC. Familial bilateral multiple fibroadenomas of the breast. Postgraduate medical journal 1985. link

Benign fibroadenoma